Randomized double-blind trial of prophylactic topical Evozac(®) Calming Skin Spray for gefitinib-associated acne-like eruption

BACKGROUND: “Gefitinib” is a first-generation epidermal growth factor receptor tyrosine-kinase inhibitor. More than half of patients receiving gefitinib develop acne-like eruption. Evozac(®) Calming Skin Spray (Evaux Laboratoires, Évaux-les-Bains, France) is made of Évaux thermal spring water and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yalan, Yang, Yunpeng, Xu, Jinxia, Yu, Juan, Liu, Xia, Gao, Ruizhen, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096493/
https://www.ncbi.nlm.nih.gov/pubmed/25031540
http://dx.doi.org/10.2147/OTT.S65961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096493/
https://www.ncbi.nlm.nih.gov/pubmed/25031540
http://dx.doi.org/10.2147/OTT.S65961

Ejemplares similares